Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    GO27820
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer
Condition: Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Placebo;   Drug: cisplatin/carboplatin;   Drug: onartuzumab;   Drug: paclitaxel

Indicates status has not been verified in more than two years